The preliminary results described Wednesday come from two patients with multiple myeloma and one with sarcoma. This was just a first safety test, the scientists say, and was not designed to measure whether such a treatment would work.

The preliminary results described Wednesday come from two patients with multiple myeloma and one with sarcoma. This was just a first safety test, the scientists say, and was not designed to measure whether such a treatment would work.

The preliminary results described Wednesday come from two patients with multiple myeloma and one with sarcoma. This was just a first safety test, the scientists say, and was not designed to measure whether such a treatment would work.

The preliminary results described Wednesday come from two patients with multiple myeloma and one with sarcoma. This was just a first safety test, the scientists say, and was not designed to measure whether such a treatment would work.